Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A Spatiotemporal Atlas of Extranuclear Androgen Receptor Proximal Interaction Networks

Created on 07 Aug 2026

Authors

Ptak, C. C., O'Rourke, C., Eng, J., Radoshevich, L., Wright, M. E.

Abstract

Androgen receptor-interacting proteins (AR-IPs) comprise nearly 1,000 proteins, yet their organization across subcellular space and time remains uncharted. Proximity labeling captures direct binding partners along with neighboring proteins that populate a receptor's local environment, thereby broadening AR-IPs into a broader population of AR-proximal interacting proteins (AR-PIPs). Here, we apply proximity labeling quantitative mass spectrometry (PL-qMS) to construct a spatiotemporal atlas of the extranuclear AR-proximal interactome in LNCaP prostate tumor cells. PL-qMS recovered 82.2% of the known AR-IPs and identified 3,947 AR-PIPs across cytosolic and membrane compartments, revealing dynamic remodeling across an androgen time course. Functional enrichment and network analyses identified the retromer complex as an androgen-sensitive AR-proximal interaction, which was verified by proximity ligation assays. Partial genetic disruption of VPS26A attenuated transcription of canonical androgen-regulated genes by mislocalizing the AR coactivator TMF1, establishing the retromer-AR-TMF1 axis as a functionally validated AR-proximal interaction network (AR-PIN). This work establishes subcellular proximal proteomes as a spatiotemporal framework for probing AR function and its dysregulation in disease.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 07 Aug 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 19
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement